Variant report
Variant | esv3384307 |
---|---|
Chromosome Location | chr10:5293051-5294583 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:5285994..5288790-chr10:5292059..5294701,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376637746 | chr10:5293102-5293103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536221125 | chr10:5293103-5293104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528595628 | chr10:5293214-5293215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201326784 | chr10:5293336-5293337 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552344268 | chr10:5293338-5293339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs200690414 | chr10:5293339-5293340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79622567 | chr10:5293340-5293341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540215161 | chr10:5293355-5293356 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs3996537 | chr10:5293507-5293508 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs529601211 | chr10:5293511-5293512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537522665 | chr10:5293528-5293529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs371458132 | chr10:5293564-5293565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs191967001 | chr10:5293566-5293567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577725887 | chr10:5293574-5293575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551328670 | chr10:5293599-5293600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181739984 | chr10:5293627-5293628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554103460 | chr10:5293637-5293638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs117355579 | chr10:5293661-5293662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528101091 | chr10:5293673-5293674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs875833 | chr10:5293681-5293682 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs185224744 | chr10:5293691-5293692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560840339 | chr10:5293700-5293701 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs189693763 | chr10:5293713-5293714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs543467842 | chr10:5293714-5293715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs564873468 | chr10:5293724-5293725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182640115 | chr10:5293737-5293738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs138276436 | chr10:5293738-5293739 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs559600898 | chr10:5293825-5293826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187926553 | chr10:5293844-5293845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548491851 | chr10:5293876-5293877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368633649 | chr10:5293932-5293933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs191300517 | chr10:5293933-5293934 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117849636 | chr10:5293940-5293941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs183535211 | chr10:5293955-5293956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs80208936 | chr10:5293956-5293957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77432327 | chr10:5293974-5293975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188479243 | chr10:5294017-5294018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192550337 | chr10:5294018-5294019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs144694756 | chr10:5294021-5294022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs554914416 | chr10:5294025-5294026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs575983366 | chr10:5294071-5294072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543098609 | chr10:5294084-5294085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs7907152 | chr10:5294096-5294097 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs576897833 | chr10:5294121-5294122 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570359197 | chr10:5294125-5294126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs141511347 | chr10:5294152-5294153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs146190553 | chr10:5294153-5294154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568088531 | chr10:5294190-5294191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2398152 | chr10:5294191-5294192 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs148058641 | chr10:5294207-5294208 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Sudden cardiac death | 19188705 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Cancer | 21129771 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Wilms tumour | 19047088 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Barakat syndrome | 22470819 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Autism | 18414403 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Breast cancer | 22032731 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 17363583 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:5286600-5293800 | Weak transcription | A549 | lung |
2 | chr10:5293800-5294400 | Enhancers | A549 | lung |
3 | chr10:5293800-5295000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr10:5293800-5295000 | Enhancers | HepG2 | liver |
5 | chr10:5294200-5294600 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr10:5294200-5294600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr10:5294200-5294600 | Enhancers | Esophagus | oesophagus |
8 | chr10:5294200-5294600 | Enhancers | Placenta | Placenta |
9 | chr10:5294200-5294600 | Bivalent Enhancer | Left Ventricle | heart |
10 | chr10:5294200-5294600 | Enhancers | Stomach Mucosa | stomach |
11 | chr10:5294200-5294600 | Enhancers | HMEC | breast |
12 | chr10:5294200-5294800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
13 | chr10:5294200-5294800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr10:5294200-5294800 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr10:5294400-5294600 | Flanking Active TSS | A549 | lung |
16 | chr10:5294400-5294800 | Enhancers | Muscle Satellite Cultured Cells | -- |